Corrigendum: The Role of the FMN-Domain of Human Cytochrome P450 Oxidoreductase in Its Promiscuous Interactions With Structurally Diverse Redox Partners

Francisco Esteves; Diana Campelo; Bruno Costa Gomes; Philippe Urban; Sophie Bozonnet; Thomas Lautier; José Rueff; Gilles Truan; Michel Kranendonk

doi:10.3389/fphar.2020.00773

Corrigendum: The Role of the FMN-Domain of Human Cytochrome P450 Oxidoreductase in Its Promiscuous Interactions With Structurally Diverse Redox Partners

Front Pharmacol. 2020 May 21:11:773. doi: 10.3389/fphar.2020.00773. eCollection 2020.

Authors

Francisco Esteves¹, Diana Campelo¹, Bruno Costa Gomes¹, Philippe Urban², Sophie Bozonnet², Thomas Lautier², José Rueff¹, Gilles Truan², Michel Kranendonk¹

Affiliations

¹ Centre for Toxicogenomics and Human Health (ToxOmics), Genetics, Oncology and Human Toxicology, NOVA Medical School, Faculty of Medical Sciences, Universidade NOVA de Lisboa, Lisbon, Portugal.
² Centre National de la Recherche Scientifique, Institut National de la Recherche Agronomique, Institut National des Sciences Appliquées de Toulouse, Toulouse Biotechnology Institute, Université de Toulouse, Toulouse, France.

Abstract

[This corrects the article DOI: 10.3389/fphar.2020.00299.].

Keywords: FMN-domain; NADPH cytochrome P450 oxidoreductase (CPR); binding motifs; cytochrome P450 monooxygenases (CYP); electron transfer; protein–protein interaction; redox partner.

Publication types

Published Erratum